HEI Therapeutics ApS: Financial statements 2023
CVR: 42613207
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
HEI Therapeutics ApS (CVR 42613207) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 3,935,885 and a net result of DKK -381,736. Equity in the 2023 report amounted to DKK -626,153. The company had 5 employees in the financial year.
- Gross Profit
- DKK 3,935,885
- Profit/Loss
- DKK -381,736
- Equity
- DKK -626,153
- Total Assets
- DKK 20,999,187
- Employees
- 5
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
HEI Therapeutics ApS has published its interim report for the period August 20, 2021 to December 31, 2022.
About HEI Therapeutics ApS
HEI Therapeutics ApS was a Danish company of the type Anpartsselskab based in København N, founded in 2021. The company has been dissolved on 30 June 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 1 employee (2025). In 2024, the company reported a gross profit of DKK 1,762,455 and a net result of DKK -12,890,414 compared with DKK -381,736 the year before. Equity in the 2024 report amounted to DKK -13,516,567.